Stanford Scientists Confirm a Natural Peptide Your Body Already Makes Can Suppress Appetite Like GLP-1s
Roughly half of people taking Ozempic and similar drugs say they experience nausea, and about a third report diarrhea, according to a 2025 RAND survey of 8,793 U.S. adults. That side-effect burden is driving a real search for alternatives, and one of the most promising candidates comes from a Stanford Medicine lab that used artificial intelligence to find a natural molecule already inside the human body.
The molecule is called BRP, short for BRINP2-related peptide. In animal studies, a single shot cut food intake by up to 50% within an hour, with no nausea, no food aversion and no significant muscle loss. If you’ve been reading about how lifestyle approaches can support the same metabolic pathways, BRP is the drug-based version of that conversation.
How This Natural GLP-1 Alternative Works
BRP is a 12-amino-acid peptide the body already produces. Stanford researchers found it using an AI tool called Peptide Predictor, which scanned more than 2,600 previously uncharacterized human peptide fragments for ones that might act like hormones. Their findings were published in Nature in March 2025.
The key difference from semaglutide, the active ingredient in Ozempic and Wegovy, is where it acts. Semaglutide hits GLP-1 receptors in the brain, gut, pancreas and other tissues, which is part of why so many users feel sick. BRP appears to work almost entirely in the hypothalamus, the brain region that controls hunger and metabolism.
In tests on lean mice and minipigs, a BRP injection before feeding reduced food intake by up to 50% within one hour, with no signs of the gastrointestinal distress or muscle wasting associated with GLP-1 drugs. BRP is not a GLP-1 agonist. It activates a different set of neurons through a related but separate metabolic pathway.
Why the Search for GLP-1 Alternatives Is So Urgent Right Now
The side-effect problem is larger than early Ozempic coverage suggested. A University of Pennsylvania team analyzed 400,000 Reddit posts from about 70,000 GLP-1 users, published in Nature Health in April 2026, and found 44% reported at least one side effect, including reproductive symptoms like menstrual changes that researchers said are often underreported. The authors noted the Reddit population skews younger and male, which limits generalizability.
Patients quitting GLP-1 drugs because of nausea, vomiting, constipation or muscle loss have created clear demand for something gentler. BRP is one candidate scientists are testing. Lifestyle approaches like time-restricted eating are the other side of that conversation.
When BRP Could Actually Be Available
Not soon. BRP has not been tested in humans, has not been reviewed by the FDA and is not available in any pharmacy, clinic or supplement aisle. Stanford says human clinical trials are expected in the near future, but every new drug must clear safety trials, dosing studies and efficacy trials before approval.
The word “natural” is also being used in a narrow scientific sense. BRP occurs naturally inside the body. It cannot be eaten, brewed or bought as a supplement.
One financial interest worth noting: lead author Katrin Svensson and co-author Laetitia Coassolo are listed as inventors on patents tied to BRP peptides, and Svensson co-founded Merrifield Therapeutics, which plans to commercialize the drug. The research was funded by the National Institutes of Health.
What This Means if You’re on Ozempic Right Now
Nothing changes today. BRP is years away from any prescription pad. People currently on GLP-1 drugs who are struggling with side effects should talk with their prescribing clinician about dose adjustments or other existing options.
For people exploring non-drug routes to metabolic health, lifestyle approaches remain the most accessible option. Sleep, strength training and eating patterns all influence the same hormonal systems BRP targets. The promise of the Stanford research is that the next generation of weight-loss drugs may finally separate the appetite signal from the side effects. For now, that promise is still in the lab.
This article was created by content specialists using various tools, including AI.
